<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Cent Nerv Syst Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">J Cent Nerv Syst Dis</journal-id>
<journal-id journal-id-type="publisher-id">CNS</journal-id>
<journal-id journal-id-type="hwp">spcns</journal-id>
<journal-title-group>
<journal-title>Journal of Central Nervous System Disease</journal-title>
</journal-title-group>
<issn pub-type="epub">1179-5735</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31205438</article-id>
<article-id pub-id-type="pmc">6537489</article-id>
<article-id pub-id-type="doi">10.1177/1179573519849938</article-id>
<article-id pub-id-type="publisher-id">10.1177_1179573519849938</article-id>
<article-id pub-id-type="publisher-manuscript">CNS-18-0019.R3</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Biallelic <italic>SCN2A</italic> Gene Mutation Causing Early Infantile Epileptic Encephalopathy: Case Report and Review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>AlSaif</surname>
<given-names>Shahad</given-names>
</name>
<xref ref-type="aff" rid="aff1-1179573519849938">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Umair</surname>
<given-names>Muhammad</given-names>
</name>
<xref ref-type="aff" rid="aff2-1179573519849938">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-9427-7240</contrib-id>
<name>
<surname>Alfadhel</surname>
<given-names>Majid</given-names>
</name>
<xref ref-type="aff" rid="aff2-1179573519849938">2</xref>
<xref ref-type="aff" rid="aff3-1179573519849938">3</xref>
<xref ref-type="corresp" rid="corresp1-1179573519849938"></xref>
</contrib>
</contrib-group>
<aff id="aff1-1179573519849938"><label>1</label>College of Medicine, King Saud bin Abdulaziz University for Health Science, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs (NGHA), Riyadh, Saudi Arabia</aff>
<aff id="aff2-1179573519849938"><label>2</label>Medical Genomics Research Department, King Abdullah International Medical Research Center (KAIMRC), King Saud bin Abdulaziz University for Health Science, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs (NGHA), Riyadh, Saudi Arabia</aff>
<aff id="aff3-1179573519849938"><label>3</label>Division of Genetics, Department of Pediatrics, King Saud bin Abdulaziz University for Health Science, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs (NGHA), Riyadh, Saudi Arabia</aff>
<author-notes>
<corresp id="corresp1-1179573519849938">Majid Alfadhel, Division of Genetics, Department of Pediatrics, King Saud bin Abdulaziz University for Health Science, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs (NGHA), PO Box 22490, Riyadh 11426, Saudi Arabia. Email: <email>dralfadhelm@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>11</volume>
<elocation-id>1179573519849938</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>6</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>4</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2019</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder content-type="sage">SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses</copyright-holder>
<license license-type="creative-commons" xlink:href="http://www.creativecommons.org/licenses/by-nc/4.0/">
<license-p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (<ext-link ext-link-type="uri" xlink:href="http://www.creativecommons.org/licenses/by-nc/4.0/">http://www.creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>The voltage-gated sodium channel neuronal type 2 alpha subunit (Na<sub>v</sub>α1.2) encoded by the <italic>SCN2A</italic> gene causes early infantile epileptic encephalopathy (EIEE) inherited in an autosomal dominant manner. Clinically, it has variable presentations, ranging from benign familial infantile seizures (BFIS) to severe EIEE. Diagnosis is achieved through molecular DNA testing of the <italic>SCN2A</italic> gene. Herein, we report on a 30-month-old Saudi girl who presented on the fourth day of life with EIEE, normal brain magnetic resonance imaging (MRI), normal electroencephalography (EEG), and well-controlled seizures. Genetic investigation revealed a novel homozygous missense mutation (c.5242A &gt; G; p.Asn1748Asp) in the <italic>SCN2A</italic> gene (NM_001040142.1). This is the first reported autosomal recessive inheritance of a disease allele in the <italic>SCN2A</italic> and therefore expands the molecular and inheritance spectrum of the <italic>SCN2A</italic> gene defects.</p>
</abstract>
<kwd-group>
<kwd>
<italic>SCN2A</italic>
</kwd>
<kwd>early infantile epileptic encephalopathy</kwd>
<kwd>benign familial infantile seizure</kwd>
<kwd>epilepsy</kwd>
<kwd>seizure</kwd>
<kwd>sodium channel</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>January-December 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="section1-1179573519849938" sec-type="intro">
<title>Introduction</title>
<p>The sodium channel neuronal type 2 alpha subunit (<italic>SCN2A</italic>) gene encodes the voltage-gated sodium channel Na<sub>v</sub>α1.2 which is mainly responsible for the generation of action potentials in excitable cells.<sup><xref ref-type="bibr" rid="bibr1-1179573519849938">1</xref></sup> Any mutation that causes loss of function (LOF) or changes the secondary structure of the SCN2A protein might result in the disruption of the sodium channel function. This might cause loss or decreased excitability of the neuronal cells, which contributes to autism spectrum disorder, or might cause hyperexcitability of neuronal cells, which is characterized as infantile seizures.<sup><xref ref-type="bibr" rid="bibr2-1179573519849938">2</xref></sup> However, LOF, which does not result in hyperexcitable neurons, can still cause severe phenotypes with seizures.<sup><xref ref-type="bibr" rid="bibr3-1179573519849938">3</xref></sup> Later in development, reduced excitability of unmyelinated cortical inhibitory neurons might lead to hyperexcitable cortical networks. Any pathogenesis due to SCN2A LOF might affect inhibitory/excitatory balance, which gives rise to seizures, neuropsychiatric disorders, and autism.<sup><xref ref-type="bibr" rid="bibr3-1179573519849938">3</xref></sup></p>
<p>The most common clinical presentation of <italic>SCN2A</italic> defect is the benign familial infantile seizures type 3 (BFIS3; MIM 607745), which is an autosomal dominant neurological disorder, characterized by apnea, cyanosis, and cluster seizures that occur over one or several days.<sup><xref ref-type="bibr" rid="bibr4-1179573519849938">4</xref></sup> The seizures are mostly focal, consisting of twitching of the limbs with the head turned, lips smacking, blinking of the eye, and staring episodes.<sup><xref ref-type="bibr" rid="bibr5-1179573519849938">5</xref>,<xref ref-type="bibr" rid="bibr6-1179573519849938">6</xref></sup> Patients may also present secondary generalized seizures.<sup><xref ref-type="bibr" rid="bibr6-1179573519849938">6</xref></sup> Usually, seizures cease at the end of the first year of life, yet some continue to have seizures through adulthood without any subsequent abnormality in neurological development.<sup><xref ref-type="bibr" rid="bibr5-1179573519849938">5</xref>,<xref ref-type="bibr" rid="bibr6-1179573519849938">6</xref></sup> Electroencephalography (EEG) and magnetic resonance imaging (MRI) in these patients have insignificant results. Another phenotype associated with <italic>SCN2A</italic> pathogenesis include the early infantile epileptic encephalopathy type 11 (EIEE11), having autosomal dominant inheritance of the neurological disease, exhibiting a more severe neurological manifestation.<sup><xref ref-type="bibr" rid="bibr7-1179573519849938">7</xref>,<xref ref-type="bibr" rid="bibr8-1179573519849938">8</xref></sup> Patients with EIEE present early onset of infantile refractory seizures, which eventually lead to a marked delay in intellectual and motor development.<sup><xref ref-type="bibr" rid="bibr7-1179573519849938">7</xref>,<xref ref-type="bibr" rid="bibr9-1179573519849938">9</xref></sup> Initially, patients may present features such as neonatal hypotonia that proceeds to partial seizure along with generalized refractory tonic-clonic seizures, which might further progress to Ohtahara and West syndromes.<sup><xref ref-type="bibr" rid="bibr10-1179573519849938">10</xref>,<xref ref-type="bibr" rid="bibr11-1179573519849938">11</xref></sup> Patients might exhibit dysphagia, dysarthria, excessive daytime sleepiness, disturbed visual contact, and in severe cases, paralysis.<sup><xref ref-type="bibr" rid="bibr7-1179573519849938">7</xref>,<xref ref-type="bibr" rid="bibr8-1179573519849938">8</xref>,<xref ref-type="bibr" rid="bibr10-1179573519849938">10</xref></sup> Brain MRI of these patients can show a variety of findings, with brain atrophy commonly reported.<sup><xref ref-type="bibr" rid="bibr9-1179573519849938">9</xref>,<xref ref-type="bibr" rid="bibr10-1179573519849938">10</xref>,<xref ref-type="bibr" rid="bibr12-1179573519849938">12</xref></sup> As with MRI, EEG findings vary among patients, mostly showing hypsarrhythmia and focal or multifocal sharp waves.<sup><xref ref-type="bibr" rid="bibr7-1179573519849938">7</xref>,<xref ref-type="bibr" rid="bibr8-1179573519849938">8</xref>,<xref ref-type="bibr" rid="bibr12-1179573519849938">12</xref></sup></p>
<p>To our knowledge, all the previously reported cases of <italic>SCN2A</italic> gene defects are inherited in dominant heterozygous state or de novo state, and there is no previously reported case having an autosomal recessive inheritance having homozygous variant in the <italic>SCN2A</italic> gene. Herein, we report the first patient with a biallelic missense mutation in the <italic>SCN2A</italic> gene with an autosomal recessive inheritance.</p>
</sec>
<sec id="section2-1179573519849938" sec-type="cases">
<title>Case Report</title>
<p>The patient is a 30-month-old Saudi girl born full term via elective cesarean section to first cousin parents with an uneventful pregnancy. She is the fourth child of her parents with three older siblings. At birth, she had a length of 48 cm (10th-25th centile), weight of 3 kg (10th-25th centile), head circumference (HC) of 34 cm (10th-25th centile), and Apgar scores of 9 and 10 at 1 and 5 minutes, respectively. After discharge at 4 days of age, she presented with neonatal seizures described as mouth and eye deviation and jerking movement of the upper and lower limbs for one minute. At 1 month of age, the proband was alert, awake, afebrile, and she was prescribed phenobarbital and phenytoin after initiating appropriate investigations, including septic work up, brain computed tomography (CT), lumber puncture, EEG, and MRI of the brain. A week later, patient seizures were determined to be controlled on phenytoin and phenobarbital, and she was discharged as a follow-up patient with the pediatric neurology department. Later, she presented with multiple emergency department (ED) visits complaining mainly of seizures ranging from blinking and spasmodic hiccups to classical tonic-clonic movement, upon which she was electively admitted for further investigation, including long-term EEG monitoring and genetic consultation. Abnormal EEG results led to the addition of levetiracetam to the previous regimen.</p>
<sec id="section3-1179573519849938">
<title>Follow-up examination</title>
<p>Other than the symptoms mentioned above, the patient is thriving appropriately for her age and has no other medical problems. On examination at 30 months of age, her measurements were as follows: height 87 cm (10th-25th centile), weight 12 kg (10th-25th centile), and HC 48 cm (25th-50th centile). The patient generally looks well; is awake, alert, and active; and is not dysmorphic, with normal tone and power and normal gait and coordination. She is vitally stable and has unremarkable central nervous system (CNS) and other system examination results.</p>
<p>Multiple EEGs were performed, all with normal findings. Pediatric long-term monitoring (LTM) initially revealed abnormal sleep and awake readings, yet subsequent repeated LTM/EEGs were within normal limits. Brain MRI, abdominal ultrasound, cystourethrogram, renal ultrasound, auditory brainstem response, echocardiogram, and ophthalmology evaluations were normal. Complete blood count, serum drug and toxicity levels, renal profile, liver profile, and cerebrospinal fluid (CSF) assays for cell counts, protein, and glucose levels, stool and urine analyses were all normal.</p>
</sec>
<sec id="section4-1179573519849938">
<title>Laboratory test</title>
<p>All of the following biochemical and genetic investigations were unremarkable: acylcarnitine profile, ammonia, lactic acid, creatine kinase, total homocysteine, urine amino acids, urine organic acids, coagulation profile, lipid profile, very long chain fatty acids, urine for creatine and guanidinoacetate, urine for purine and pyrimidines, chromosomal analysis, and comparative genomic hybridization (CGH) microarray.</p>
</sec>
</sec>
<sec id="section5-1179573519849938">
<title>Genetic and Molecular Analysis</title>
<sec id="section6-1179573519849938">
<title>Genomic DNA extraction</title>
<p>The present study was performed after the approval of institutional review board (IRB), followed by Helsinki protocols, and written informed consent was obtained from the patient’s parents to publish this case report. Genomic DNA was extracted using commercially available kit and quantified using standard methods.</p>
</sec>
<sec id="section7-1179573519849938">
<title>Gene panel</title>
<p>Genetic testing with an EIEE gene panel (Centogene, Germany) identified a homozygous missense mutation (c.5242A &gt; G; p.Asn1748Asp) in <italic>SCN2A</italic> (NM_001040142.1) located on chromosome 2q24.3.</p>
</sec>
<sec id="section8-1179573519849938">
<title>Sanger sequencing</title>
<p>Segregation analysis of the identified homozygous variant was undertaken for both the parents, three siblings using standard methods, and showed that the parents and two siblings were heterozygous carriers, while one healthy sister is wild type.</p>
<p>The parents were comprehensively counseled regarding the genetic results, its mode of inheritance, and the recurrence risk of 25% in each pregnancy. The patient’s seizures are well controlled with phenobarbital and levetiracetam, and she has normal development with no deterioration or complications.</p>
</sec>
</sec>
<sec id="section9-1179573519849938" sec-type="discussion">
<title>Discussion</title>
<p>The present report describes the first documented homozygous <italic>SCN2A</italic> mutation causing EIEE in autosomal recessive manner, as all previously reported patients were reported having heterozygous <italic>SCN2A</italic> variant in either dominant or de novo fashion. The pathogenicity of the variant (c.5242A &gt; G; p.Asn1748Asp) reported here is supported by segregation within the family. Furthermore, the variant is rare and not described in homozygous or heterozygous state in the Exome Aggregation Consortium (ExAC), Genome Aggregation Database (gnomAD), Exome Variant Server (EVS), or 1000 Genomes Project and in 2000 in-house ethnically matched exomes. In addition, computational analysis tools, including PolyPhen, SIFT, MutationTaster, and phyloP, predict this variant to be most likely damaging.</p>
<p>Pathogenic heterozygous and de novo mutations in the <italic>SCN2A</italic> gene have been reported with two causes: EIEE11 (MIM 613721) and BFIS3 (MIM 607745). <xref ref-type="table" rid="table1-1179573519849938">Table 1</xref> summarizes the patients reported to have EIEE due to either heterozygous or de novo mutations within the <italic>SCN2A</italic> gene.<sup><xref ref-type="bibr" rid="bibr7-1179573519849938">7</xref>,<xref ref-type="bibr" rid="bibr12-1179573519849938">12</xref><xref ref-type="bibr" rid="bibr13-1179573519849938"></xref><xref ref-type="bibr" rid="bibr14-1179573519849938"></xref><xref ref-type="bibr" rid="bibr15-1179573519849938"></xref><xref ref-type="bibr" rid="bibr16-1179573519849938"></xref><xref ref-type="bibr" rid="bibr17-1179573519849938"></xref><xref ref-type="bibr" rid="bibr18-1179573519849938"></xref><xref ref-type="bibr" rid="bibr19-1179573519849938"></xref><xref ref-type="bibr" rid="bibr20-1179573519849938"></xref><xref ref-type="bibr" rid="bibr21-1179573519849938"></xref><xref ref-type="bibr" rid="bibr22-1179573519849938"></xref><xref ref-type="bibr" rid="bibr23-1179573519849938"></xref><xref ref-type="bibr" rid="bibr24-1179573519849938"></xref><xref ref-type="bibr" rid="bibr25-1179573519849938"></xref><xref ref-type="bibr" rid="bibr26-1179573519849938"></xref><xref ref-type="bibr" rid="bibr27-1179573519849938"></xref><xref ref-type="bibr" rid="bibr28-1179573519849938"></xref><xref ref-type="bibr" rid="bibr29-1179573519849938"></xref><xref ref-type="bibr" rid="bibr30-1179573519849938"></xref><xref ref-type="bibr" rid="bibr31-1179573519849938"></xref><xref ref-type="bibr" rid="bibr32-1179573519849938"></xref><xref ref-type="bibr" rid="bibr33-1179573519849938"></xref><xref ref-type="bibr" rid="bibr34-1179573519849938"></xref><xref ref-type="bibr" rid="bibr35-1179573519849938"></xref><xref ref-type="bibr" rid="bibr36-1179573519849938"></xref><xref ref-type="bibr" rid="bibr37-1179573519849938"></xref><xref ref-type="bibr" rid="bibr38-1179573519849938"></xref><xref ref-type="bibr" rid="bibr39-1179573519849938"></xref><xref ref-type="bibr" rid="bibr40-1179573519849938"></xref><xref ref-type="bibr" rid="bibr41-1179573519849938"></xref><xref ref-type="bibr" rid="bibr42-1179573519849938"></xref><xref ref-type="bibr" rid="bibr43-1179573519849938"></xref><xref ref-type="bibr" rid="bibr44-1179573519849938"></xref><xref ref-type="bibr" rid="bibr45-1179573519849938"></xref><xref ref-type="bibr" rid="bibr46-1179573519849938"></xref><xref ref-type="bibr" rid="bibr47-1179573519849938"></xref><xref ref-type="bibr" rid="bibr48-1179573519849938"></xref><xref ref-type="bibr" rid="bibr49-1179573519849938"></xref><xref ref-type="bibr" rid="bibr50-1179573519849938"></xref><xref ref-type="bibr" rid="bibr51-1179573519849938"></xref><xref ref-type="bibr" rid="bibr52-1179573519849938"></xref><xref ref-type="bibr" rid="bibr53-1179573519849938"></xref><xref ref-type="bibr" rid="bibr54-1179573519849938"></xref><xref ref-type="bibr" rid="bibr55-1179573519849938"></xref><xref ref-type="bibr" rid="bibr56-1179573519849938"></xref><xref ref-type="bibr" rid="bibr57-1179573519849938"></xref><xref ref-type="bibr" rid="bibr58-1179573519849938"></xref><xref ref-type="bibr" rid="bibr59-1179573519849938"></xref><xref ref-type="bibr" rid="bibr60-1179573519849938"></xref><xref ref-type="bibr" rid="bibr61-1179573519849938"></xref><xref ref-type="bibr" rid="bibr62-1179573519849938"></xref><xref ref-type="bibr" rid="bibr63-1179573519849938"></xref><xref ref-type="bibr" rid="bibr64-1179573519849938"></xref><xref ref-type="bibr" rid="bibr65-1179573519849938"></xref><xref ref-type="bibr" rid="bibr66-1179573519849938"></xref><xref ref-type="bibr" rid="bibr67-1179573519849938"></xref><xref ref-type="bibr" rid="bibr68-1179573519849938"></xref><xref ref-type="bibr" rid="bibr69-1179573519849938"></xref><xref ref-type="bibr" rid="bibr70-1179573519849938"></xref><xref ref-type="bibr" rid="bibr71-1179573519849938"></xref><xref ref-type="bibr" rid="bibr72-1179573519849938"></xref><xref ref-type="bibr" rid="bibr73-1179573519849938"></xref><xref ref-type="bibr" rid="bibr74-1179573519849938"></xref><xref ref-type="bibr" rid="bibr75-1179573519849938"></xref><xref ref-type="bibr" rid="bibr76-1179573519849938"></xref><xref ref-type="bibr" rid="bibr77-1179573519849938"></xref><xref ref-type="bibr" rid="bibr78-1179573519849938"></xref><xref ref-type="bibr" rid="bibr79-1179573519849938"></xref><xref ref-type="bibr" rid="bibr80-1179573519849938"></xref><xref ref-type="bibr" rid="bibr81-1179573519849938"></xref><xref ref-type="bibr" rid="bibr82-1179573519849938"></xref><xref ref-type="bibr" rid="bibr83-1179573519849938"></xref><xref ref-type="bibr" rid="bibr84-1179573519849938"></xref><xref ref-type="bibr" rid="bibr85-1179573519849938"></xref><xref ref-type="bibr" rid="bibr86-1179573519849938"></xref><xref ref-type="bibr" rid="bibr87-1179573519849938"></xref><xref ref-type="bibr" rid="bibr88-1179573519849938"></xref><xref ref-type="bibr" rid="bibr89-1179573519849938"></xref>–<xref ref-type="bibr" rid="bibr90-1179573519849938">90</xref></sup> According to Human Gene Mutation Database (HGMD, 2018), 268 mutations have been reported in the <italic>SCN2A</italic> gene presenting diverse phenotypes (<xref ref-type="table" rid="table2-1179573519849938">Table 2</xref>). We identified a total of 290 cases having heterozygous or de novo <italic>SCN2A</italic> gene mutations in the literature survey. Approximately 87.24% of cases reported several types of seizures, including BFIS, benign familial neonatal epilepsy, refractory neonatal epilepsy, infantile spasm, episodic ataxia, acute encephalopathy, recurrent encephalopathy, and EIEE, as observed in the present case. Other reported symptoms included autism (21.3%), severe pulmonary emphysema (4.48%), migrating focal seizures of infancy (6.55%), paroxysmal ataxia in toddler (4.48%), developmental delay (31.37%), Ohtahara syndrome (4.85%), West syndrome (1.37%), and Lennox-Gastaut syndrome (0.68%). The ages of symptom onset ranged from a few hours after birth up to 6.6 years. None of the previously reported cases were documented with parental consanguinity as described in our case. Regarding clinical features, 14.48% had normal features, 24.82% presented with hypotonia, 7.93% with ataxic gait, and 3.10% with spasticity. EEGs showed normal findings in 12.75%, including the current patient. Brain MRI was normal in our patient and in 19.31% of cases in literature. Moreover, 27.93% demonstrated cerebral atrophy, 13.44% showed hypoplastic corpus callosum, 18.27% suffered from cerebellar atrophy, and 3.10% had lesions in the right parietal/temporal/occipital lobes. The following features were observed in 5.86% of cases such as cortical/subcortical edema, diffuse abnormalities of white matter, lack of differentiation between cortex and subcortical layers with pachygyria and anomalies of the cortical gyration, and immature myelination at the bilateral periventricular areas. Up to 47.90% of cases were reported to have a family history of seizures; however, the current case had a negative family history of seizures. In total, 36 (12.41%) of cases reported so far were deceased, and the age at death ranged from 5 to 75 years old.</p>
<table-wrap id="table1-1179573519849938" orientation="portrait" position="float">
<label>Table 1.</label>
<caption>
<p>Comparison of the current case with previously reported cases having <italic>SCN2A</italic> gene defects.<sup><xref ref-type="bibr" rid="bibr7-1179573519849938">7</xref>,<xref ref-type="bibr" rid="bibr12-1179573519849938">12</xref><xref ref-type="bibr" rid="bibr13-1179573519849938"></xref><xref ref-type="bibr" rid="bibr14-1179573519849938"></xref><xref ref-type="bibr" rid="bibr15-1179573519849938"></xref><xref ref-type="bibr" rid="bibr16-1179573519849938"></xref><xref ref-type="bibr" rid="bibr17-1179573519849938"></xref><xref ref-type="bibr" rid="bibr18-1179573519849938"></xref><xref ref-type="bibr" rid="bibr19-1179573519849938"></xref><xref ref-type="bibr" rid="bibr20-1179573519849938"></xref><xref ref-type="bibr" rid="bibr21-1179573519849938"></xref><xref ref-type="bibr" rid="bibr22-1179573519849938"></xref><xref ref-type="bibr" rid="bibr23-1179573519849938"></xref><xref ref-type="bibr" rid="bibr24-1179573519849938"></xref><xref ref-type="bibr" rid="bibr25-1179573519849938"></xref><xref ref-type="bibr" rid="bibr26-1179573519849938"></xref><xref ref-type="bibr" rid="bibr27-1179573519849938"></xref><xref ref-type="bibr" rid="bibr28-1179573519849938"></xref><xref ref-type="bibr" rid="bibr29-1179573519849938"></xref><xref ref-type="bibr" rid="bibr30-1179573519849938"></xref><xref ref-type="bibr" rid="bibr31-1179573519849938"></xref><xref ref-type="bibr" rid="bibr32-1179573519849938"></xref><xref ref-type="bibr" rid="bibr33-1179573519849938"></xref><xref ref-type="bibr" rid="bibr34-1179573519849938"></xref><xref ref-type="bibr" rid="bibr35-1179573519849938"></xref><xref ref-type="bibr" rid="bibr36-1179573519849938"></xref><xref ref-type="bibr" rid="bibr37-1179573519849938"></xref><xref ref-type="bibr" rid="bibr38-1179573519849938"></xref><xref ref-type="bibr" rid="bibr39-1179573519849938"></xref><xref ref-type="bibr" rid="bibr40-1179573519849938"></xref><xref ref-type="bibr" rid="bibr41-1179573519849938"></xref><xref ref-type="bibr" rid="bibr42-1179573519849938"></xref><xref ref-type="bibr" rid="bibr43-1179573519849938"></xref><xref ref-type="bibr" rid="bibr44-1179573519849938"></xref><xref ref-type="bibr" rid="bibr45-1179573519849938"></xref><xref ref-type="bibr" rid="bibr46-1179573519849938"></xref><xref ref-type="bibr" rid="bibr47-1179573519849938"></xref><xref ref-type="bibr" rid="bibr48-1179573519849938"></xref><xref ref-type="bibr" rid="bibr49-1179573519849938"></xref><xref ref-type="bibr" rid="bibr50-1179573519849938"></xref><xref ref-type="bibr" rid="bibr51-1179573519849938"></xref><xref ref-type="bibr" rid="bibr52-1179573519849938"></xref><xref ref-type="bibr" rid="bibr53-1179573519849938"></xref><xref ref-type="bibr" rid="bibr54-1179573519849938"></xref><xref ref-type="bibr" rid="bibr55-1179573519849938"></xref><xref ref-type="bibr" rid="bibr56-1179573519849938"></xref><xref ref-type="bibr" rid="bibr57-1179573519849938"></xref><xref ref-type="bibr" rid="bibr58-1179573519849938"></xref><xref ref-type="bibr" rid="bibr59-1179573519849938"></xref><xref ref-type="bibr" rid="bibr60-1179573519849938"></xref><xref ref-type="bibr" rid="bibr61-1179573519849938"></xref><xref ref-type="bibr" rid="bibr62-1179573519849938"></xref><xref ref-type="bibr" rid="bibr63-1179573519849938"></xref><xref ref-type="bibr" rid="bibr64-1179573519849938"></xref><xref ref-type="bibr" rid="bibr65-1179573519849938"></xref><xref ref-type="bibr" rid="bibr66-1179573519849938"></xref><xref ref-type="bibr" rid="bibr67-1179573519849938"></xref><xref ref-type="bibr" rid="bibr68-1179573519849938"></xref><xref ref-type="bibr" rid="bibr69-1179573519849938"></xref><xref ref-type="bibr" rid="bibr70-1179573519849938"></xref><xref ref-type="bibr" rid="bibr71-1179573519849938"></xref><xref ref-type="bibr" rid="bibr72-1179573519849938"></xref><xref ref-type="bibr" rid="bibr73-1179573519849938"></xref><xref ref-type="bibr" rid="bibr74-1179573519849938"></xref><xref ref-type="bibr" rid="bibr75-1179573519849938"></xref><xref ref-type="bibr" rid="bibr76-1179573519849938"></xref><xref ref-type="bibr" rid="bibr77-1179573519849938"></xref><xref ref-type="bibr" rid="bibr78-1179573519849938"></xref><xref ref-type="bibr" rid="bibr79-1179573519849938"></xref><xref ref-type="bibr" rid="bibr80-1179573519849938"></xref><xref ref-type="bibr" rid="bibr81-1179573519849938"></xref><xref ref-type="bibr" rid="bibr82-1179573519849938"></xref><xref ref-type="bibr" rid="bibr83-1179573519849938"></xref><xref ref-type="bibr" rid="bibr84-1179573519849938"></xref><xref ref-type="bibr" rid="bibr85-1179573519849938"></xref><xref ref-type="bibr" rid="bibr86-1179573519849938"></xref><xref ref-type="bibr" rid="bibr87-1179573519849938"></xref><xref ref-type="bibr" rid="bibr88-1179573519849938"></xref><xref ref-type="bibr" rid="bibr89-1179573519849938"></xref>–<xref ref-type="bibr" rid="bibr90-1179573519849938">90</xref></sup></p>
</caption>
<alternatives>
<graphic xlink:href="10.1177_1179573519849938-table1"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
</colgroup>
<thead>
<tr>
<th colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">Previously reported cases</th>
<th align="left" colspan="1" rowspan="1">Present case</th>
<th align="left" colspan="1" rowspan="1">%</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">Number of cases</td>
<td colspan="1" rowspan="1">290</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">291</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Origin</td>
<td colspan="1" rowspan="1">Denmark (71), Canada (8), China (28), England (11), Czech Republic (2), Turkey (1), Switzerland (5), Australia (40), Taiwan (2), Italy (15), U.S.A (56), Japan (22), UK (7), Sweden (20), and France (2)</td>
<td colspan="1" rowspan="1">Saudi Arabia</td>
<td colspan="1" rowspan="1">Most common from Denmark</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Type of inheritance</td>
<td colspan="1" rowspan="1">Heterozygous, AD</td>
<td colspan="1" rowspan="1">Homozygous, AR</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="4" rowspan="1">
<italic>Neurological symptoms</italic>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Family history of seizures</td>
<td colspan="1" rowspan="1">139</td>
<td colspan="1" rowspan="1">Negative</td>
<td colspan="1" rowspan="1">47.9</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Type of seizures</td>
<td colspan="1" rowspan="1">Benign familial infantile seizures, benign familial neonatal epilepsy, childhood seizures, early infantile epileptic encephalopathy, epileptic encephalopathy, episodic ataxia, febrile seizures, infantile epilepsy, infantile spasms, intractable epilepsy, migrating focal seizures of infancy, neonatal epileptic encephalopathy, neonatal seizures, and recurrent encephalopathy (253)</td>
<td colspan="1" rowspan="1">Early infantile epileptic encephalopathy</td>
<td colspan="1" rowspan="1">87.24</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Autism</td>
<td colspan="1" rowspan="1">62</td>
<td colspan="1" rowspan="1">Not observed</td>
<td colspan="1" rowspan="1">21.3</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Migrating focal seizures of infancy</td>
<td colspan="1" rowspan="1">19</td>
<td colspan="1" rowspan="1">Not observed</td>
<td colspan="1" rowspan="1">6.55</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Paroxysmal ataxia in toddler</td>
<td colspan="1" rowspan="1">13</td>
<td colspan="1" rowspan="1">Not observed</td>
<td colspan="1" rowspan="1">4.48</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Ohtahara syndrome</td>
<td colspan="1" rowspan="1">14</td>
<td colspan="1" rowspan="1">Not observed</td>
<td colspan="1" rowspan="1">4.82</td>
</tr>
<tr>
<td colspan="1" rowspan="1">West syndrome</td>
<td colspan="1" rowspan="1">4</td>
<td colspan="1" rowspan="1">Not observed</td>
<td colspan="1" rowspan="1">1.37</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Lennox-Gastaut syndrome</td>
<td colspan="1" rowspan="1">2</td>
<td colspan="1" rowspan="1">Not observed</td>
<td colspan="1" rowspan="1">0.68</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Normal</td>
<td colspan="1" rowspan="1">42</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">14.48</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Developmental delay</td>
<td colspan="1" rowspan="1">91</td>
<td colspan="1" rowspan="1">Not observed</td>
<td colspan="1" rowspan="1">31.37</td>
</tr>
<tr>
<td colspan="4" rowspan="1">
<italic>Neurological examination</italic>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Dysmorphic features</td>
<td colspan="1" rowspan="1">48</td>
<td colspan="1" rowspan="1">Not observed</td>
<td colspan="1" rowspan="1">16.55</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Hypotonia</td>
<td colspan="1" rowspan="1">72</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">24.82</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Ataxic gait</td>
<td colspan="1" rowspan="1">23</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">7.93</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Spasticity</td>
<td colspan="1" rowspan="1">9</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">3.10</td>
</tr>
<tr>
<td colspan="4" rowspan="1"><italic>Electroencephalogram findings</italic> (187 of 290)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Normal</td>
<td colspan="1" rowspan="1">37</td>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">12.75</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Abnormal (EEG) findings</td>
<td colspan="1" rowspan="1">Extremely variable and include multifocal poly spike activity, hypsarrhythmia, burst suppression pattern, and diffuse slowing (123)</td>
<td colspan="1" rowspan="1">Normal</td>
<td colspan="1" rowspan="1">42.41</td>
</tr>
<tr>
<td colspan="4" rowspan="1"><italic>MRI findings</italic> (175 of 290)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Normal</td>
<td colspan="1" rowspan="1">56</td>
<td colspan="1" rowspan="1">Normal</td>
<td colspan="1" rowspan="1">19.31</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cerebral atrophy</td>
<td colspan="1" rowspan="1">81</td>
<td colspan="1" rowspan="1">Not observed</td>
<td colspan="1" rowspan="1">27.93</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Hypoplastic corpus callosum</td>
<td colspan="1" rowspan="1">39</td>
<td colspan="1" rowspan="1">Not observed</td>
<td colspan="1" rowspan="1">13.44</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cerebellar atrophy</td>
<td colspan="1" rowspan="1">53</td>
<td colspan="1" rowspan="1">Not observed</td>
<td colspan="1" rowspan="1">18.27</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Lesions in right parietal/temporal/occipital lobes</td>
<td colspan="1" rowspan="1">9</td>
<td colspan="1" rowspan="1">Not observed</td>
<td colspan="1" rowspan="1">3.10</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cortical/subcortical edema</td>
<td colspan="1" rowspan="1">7</td>
<td colspan="1" rowspan="1">Not observed</td>
<td colspan="1" rowspan="1">2.41</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Diffuse abnormalities of white matter</td>
<td colspan="1" rowspan="1">15</td>
<td colspan="1" rowspan="1">Not observed</td>
<td colspan="1" rowspan="1">5.17</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Lack of differentiation between cortex and subcortical layers with pachygyria and anomalies of the cortical gyration</td>
<td colspan="1" rowspan="1">17</td>
<td colspan="1" rowspan="1">Not observed</td>
<td colspan="1" rowspan="1">5.86</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Immature myelination at the bilateral periventricular areas</td>
<td colspan="1" rowspan="1">28</td>
<td colspan="1" rowspan="1">Not observed</td>
<td colspan="1" rowspan="1">9.65</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Prognosis</td>
<td colspan="1" rowspan="1">36 died</td>
<td colspan="1" rowspan="1">Alive</td>
<td colspan="1" rowspan="1">12.41</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<table-wrap id="table2-1179573519849938" orientation="portrait" position="float">
<label>Table 2.</label>
<caption>
<p>To-date mutations reported in the <italic>SCN2A</italic> gene causing different overlapping phenotypes.</p>
</caption>
<alternatives>
<graphic xlink:href="10.1177_1179573519849938-table2"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1"/>
<col align="char" char="." span="1"/>
<col align="char" char="." span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">S.No</th>
<th align="left" colspan="1" rowspan="1">Disorder caused</th>
<th align="left" colspan="1" rowspan="1">Number of mutations Reported</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">1</td>
<td colspan="1" rowspan="1">Autism spectrum disorder</td>
<td colspan="1" rowspan="1">46</td>
</tr>
<tr>
<td colspan="1" rowspan="1">2</td>
<td colspan="1" rowspan="1">Seizures</td>
<td colspan="1" rowspan="1">54</td>
</tr>
<tr>
<td colspan="1" rowspan="1">3</td>
<td colspan="1" rowspan="1">Epilepsy</td>
<td colspan="1" rowspan="1">28</td>
</tr>
<tr>
<td colspan="1" rowspan="1">4</td>
<td colspan="1" rowspan="1">Infantile spasms</td>
<td colspan="1" rowspan="1">2</td>
</tr>
<tr>
<td colspan="1" rowspan="1">5</td>
<td colspan="1" rowspan="1">Schizophrenia</td>
<td colspan="1" rowspan="1">3</td>
</tr>
<tr>
<td colspan="1" rowspan="1">6</td>
<td colspan="1" rowspan="1">Ohtahara syndrome</td>
<td colspan="1" rowspan="1">14</td>
</tr>
<tr>
<td colspan="1" rowspan="1">7</td>
<td colspan="1" rowspan="1">Lennox-Gastaut syndrome</td>
<td colspan="1" rowspan="1">2</td>
</tr>
<tr>
<td colspan="1" rowspan="1">8</td>
<td colspan="1" rowspan="1">Intellectual disability</td>
<td colspan="1" rowspan="1">16</td>
</tr>
<tr>
<td colspan="1" rowspan="1">9</td>
<td colspan="1" rowspan="1">West syndrome</td>
<td colspan="1" rowspan="1">4</td>
</tr>
<tr>
<td colspan="1" rowspan="1">10</td>
<td colspan="1" rowspan="1">Neurodevelopmental disorder</td>
<td colspan="1" rowspan="1">8</td>
</tr>
<tr>
<td colspan="1" rowspan="1">11</td>
<td colspan="1" rowspan="1">Cleft lip and/or palate</td>
<td colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">12</td>
<td colspan="1" rowspan="1">Epileptic encephalopathy</td>
<td colspan="1" rowspan="1">89</td>
</tr>
<tr>
<td colspan="1" rowspan="1">13</td>
<td colspan="1" rowspan="1">Dravet syndrome</td>
<td colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">Total</td>
<td colspan="1" rowspan="1">268</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<p>Patient with de novo or dominant heterozygous <italic>SCN2A</italic> gene mutations display epileptic phenotypes. Thus, it is not surprising that patients with a homozygous <italic>SCN2A</italic> mutation also have an epileptic phenotype. Despite the aforementioned fact, the importance of the current case relies on the following: first, this alerts the clinician to consider <italic>SCN2A</italic> gene defects in any patient presenting with seizures regardless of their family history, suggesting an autosomal recessive or autosomal dominant pattern. Second, it is confirmed that an autosomal recessive pattern may lead to more severe presentation, which is early neonatal epileptic encephalopathy rather than ataxia and autism in heterozygous probands.</p>
<p>Mutations in the <italic>SCN2A</italic> gene have a strong association with the manifestation of numerous types of seizures, along with other clinical characteristics, including autism, pulmonary emphysema, paroxysmal ataxia in toddlers, and Ohtahara syndrome. However, mutations in the <italic>SCN1A, SCN1B, SCN8A</italic>, or <italic>SCN9A</italic> genes also appear to be related to the expression of seizures. Here, we identified a novel homozygous missense mutation in the <italic>SCN2A</italic> causing EIEE; yet heterozygous <italic>SCN2A</italic> mutations can cause severe epileptic phenotypes, especially when they are de novo. Therefore, clinicians should keep in mind the <italic>SCN2A</italic> gene heterogeneity. This is also true for mutations in the <italic>SCN1A</italic> gene, with de novo mutations causing the severe Dravet syndrome. Similarly, mutations in the <italic>SCN9A</italic> have been associated with pain disorders and suggested as a genetic modifier for the Dravet syndrome, thus considered as a susceptible gene.<sup><xref ref-type="bibr" rid="bibr39-1179573519849938">39</xref><xref ref-type="bibr" rid="bibr40-1179573519849938"></xref><xref ref-type="bibr" rid="bibr41-1179573519849938"></xref><xref ref-type="bibr" rid="bibr42-1179573519849938"></xref><xref ref-type="bibr" rid="bibr43-1179573519849938"></xref><xref ref-type="bibr" rid="bibr44-1179573519849938"></xref>-<xref ref-type="bibr" rid="bibr45-1179573519849938">45</xref></sup> Moreover, <italic>SCN8A</italic> mutations are also inherited dominantly and associated with more severe manifestations of EIEE and BFIS.<sup><xref ref-type="bibr" rid="bibr46-1179573519849938">46</xref>,<xref ref-type="bibr" rid="bibr47-1179573519849938">47</xref></sup> Homozygous <italic>SCN1B</italic> mutations have been shown to cause a clinical phenotype of Dravet syndrome, while heterozygous mutations in autosomal dominant cases have been associated with generalized epilepsy and febrile seizures.<sup><xref ref-type="bibr" rid="bibr48-1179573519849938">48</xref>,<xref ref-type="bibr" rid="bibr49-1179573519849938">49</xref></sup> The limitation of the current study is being the only homozygous case described in the family and current literature making a firm inference of pathogenicity impossible; therefore, further homozygous reported cases with similar phenotype would confirm such conclusion.</p>
</sec>
<sec id="section10-1179573519849938" sec-type="conclusions">
<title>Conclusion</title>
<p>We report the first case of a homozygous <italic>SCN2A</italic> gene mutation in a female toddler from Saudi Arabia having hallmark features of EIEE in autosomal recessive manner. In addition, we describe a novel mutation that increased the mutational spectrum of <italic>SCN2A</italic>-associated pathogenesis. This finding expands the molecular and inheritance spectrum of <italic>SCN2A</italic> gene defects.</p>
</sec>
</body>
<back>
<ack>
<p>The authors are grateful to the patient and her family for their genuine support.</p>
</ack>
<fn-group>
<fn fn-type="COI-statement">
<p><bold>Declaration of Conflicting Interests:</bold>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<p><bold>Funding:</bold>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="con">
<p><bold>Author Contributions:</bold> SAS wrote the first draft and edited subsequent versions. MAF and MU wrote the final draft, edited the subsequent version, and contributed to the clinical diagnosis and management of the patients. All authors have read and approved the final draft of the manuscript.</p>
</fn>
<fn fn-type="other">
<p><bold>ORCID iD:</bold> Majid Alfadhel <inline-graphic xlink:href="10.1177_1179573519849938-img1.jpg"></inline-graphic>
<ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-9427-7240">https://orcid.org/0000-0002-9427-7240</ext-link></p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1179573519849938">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>CM</given-names></name><name><surname>Ware</surname><given-names>DH</given-names></name><name><surname>Lee</surname><given-names>SC</given-names></name><etal>et al</etal></person-group>
<article-title>Primary structure, chromosomal localization, and functional expression of a voltage-gated sodium channel from human brain</article-title>. <source/>Proc Natl Acad Sci U S A. <year>1992</year>;<volume>89</volume>:<fpage>8220</fpage>–<lpage>8224</lpage>.<pub-id pub-id-type="pmid">1325650</pub-id></mixed-citation>
</ref>
<ref id="bibr2-1179573519849938">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ben-Shalom</surname><given-names>R</given-names></name><name><surname>Keeshen</surname><given-names>CM</given-names></name><name><surname>Berrios</surname><given-names>KN</given-names></name><name><surname>An</surname><given-names>JY</given-names></name><name><surname>Sanders</surname><given-names>SJ</given-names></name><name><surname>Bender</surname><given-names>KJ.</given-names></name></person-group>
<article-title>Opposing effects on NaV1.2 function underlie differences between SCN2A variants observed in individuals with autism spectrum disorder or infantile seizures</article-title>. <source/>Biol Psychiatry. <year>2017</year>;<volume>82</volume>:<fpage>224</fpage>–<lpage>232</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopsych.2017.01.009</pub-id>.<pub-id pub-id-type="pmid">28256214</pub-id></mixed-citation>
</ref>
<ref id="bibr3-1179573519849938">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wolff</surname><given-names>M</given-names></name><name><surname>Johannesen</surname><given-names>KM</given-names></name><name><surname>Hedrich</surname><given-names>UBS</given-names></name><etal>et al</etal></person-group>
<article-title>Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders</article-title>. <source/>Brain. <year>2017</year>;<volume>140</volume>:<fpage>1316</fpage>–<lpage>1336</lpage>. doi:<pub-id pub-id-type="doi">10.1093/brain/awx054</pub-id>.<pub-id pub-id-type="pmid">28379373</pub-id></mixed-citation>
</ref>
<ref id="bibr4-1179573519849938">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shevell</surname><given-names>MI</given-names></name><name><surname>Sinclair</surname><given-names>DB</given-names></name><name><surname>Metrakos</surname><given-names>K.</given-names></name></person-group>
<article-title>Benign familial neonatal seizures: clinical and electroencephalographic characteristics</article-title>. <source/>Pediatr Neurol. <year>1986</year>;<volume>2</volume>:<fpage>272</fpage>–<lpage>275</lpage>.<pub-id pub-id-type="pmid">3508699</pub-id></mixed-citation>
</ref>
<ref id="bibr5-1179573519849938">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>RE</given-names></name><name><surname>Lacey</surname><given-names>DJ.</given-names></name></person-group>
<article-title>Benign familial neonatal-infantile seizures</article-title>. <source/>Am J Med Genet. <year>1983</year>;<volume>16</volume>:<fpage>595</fpage>–<lpage>599</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ajmg.1320160417</pub-id>.<pub-id pub-id-type="pmid">6660252</pub-id></mixed-citation>
</ref>
<ref id="bibr6-1179573519849938">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Berkovic</surname><given-names>SF</given-names></name><name><surname>Heron</surname><given-names>SE</given-names></name><name><surname>Giordano</surname><given-names>L</given-names></name><etal>et al</etal></person-group>
<article-title>Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy</article-title>. <source/>Ann Neurol. <year>2004</year>;<volume>55</volume>:<fpage>550</fpage>–<lpage>557</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ana.20029</pub-id>.<pub-id pub-id-type="pmid">15048894</pub-id></mixed-citation>
</ref>
<ref id="bibr7-1179573519849938">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ogiwara</surname><given-names>I</given-names></name><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Sawaishi</surname><given-names>Y</given-names></name><etal>et al</etal></person-group>
<article-title>De novo mutations of voltage-gated sodium channel alpha II gene SCN2A in intractable epilepsies</article-title>. <source/>Neurology. <year>2009</year>;<volume>73</volume>:<fpage>1046</fpage>–<lpage>1053</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0b013e3181b9cebc</pub-id>.<pub-id pub-id-type="pmid">19786696</pub-id></mixed-citation>
</ref>
<ref id="bibr8-1179573519849938">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Anttonen</surname><given-names>AK</given-names></name><name><surname>Liukkonen</surname><given-names>E</given-names></name><etal>et al</etal></person-group>
<article-title>SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain</article-title>. <source/>Neurology. <year>2010</year>;<volume>75</volume>:<fpage>1454</fpage>–<lpage>1458</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0b013e3181f8812e</pub-id>.<pub-id pub-id-type="pmid">20956790</pub-id></mixed-citation>
</ref>
<ref id="bibr9-1179573519849938">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kamiya</surname><given-names>K</given-names></name><name><surname>Kaneda</surname><given-names>M</given-names></name><name><surname>Sugawara</surname><given-names>T</given-names></name><etal>et al</etal></person-group>
<article-title>A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline</article-title>. <source/>J Neurosci. <year>2004</year>;<volume>24</volume>:<fpage>2690</fpage>–<lpage>2698</lpage>. doi:<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3089-03.2004</pub-id>.<pub-id pub-id-type="pmid">15028761</pub-id></mixed-citation>
</ref>
<ref id="bibr10-1179573519849938">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hackenberg</surname><given-names>A</given-names></name><name><surname>Baumer</surname><given-names>A</given-names></name><name><surname>Sticht</surname><given-names>H</given-names></name><etal>et al</etal></person-group>
<article-title>Infantile epileptic encephalopathy, transient choreoathetotic movements, and hypersomnia due to a De Novo missense mutation in the SCN2A gene</article-title>. <source/>Neuropediatrics. <year>2014</year>;<volume>45</volume>:<fpage>261</fpage>–<lpage>264</lpage>. doi:<pub-id pub-id-type="doi">10.1055/s-0034-1372302</pub-id>.<pub-id pub-id-type="pmid">24710820</pub-id></mixed-citation>
</ref>
<ref id="bibr11-1179573519849938">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Osaka</surname><given-names>H</given-names></name><etal>et al</etal></person-group>
<article-title>Clinical spectrum of SCN2A mutations expanding to Ohtahara syndrome</article-title>. <source/>Neurology. <year>2013</year>;<volume>81</volume>:<fpage>992</fpage>–<lpage>998</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0b013e3182a43e57</pub-id>.<pub-id pub-id-type="pmid">23935176</pub-id></mixed-citation>
</ref>
<ref id="bibr12-1179573519849938">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baasch</surname><given-names>AL</given-names></name><name><surname>Huning</surname><given-names>I</given-names></name><name><surname>Gilissen</surname><given-names>C</given-names></name><etal>et al</etal></person-group>
<article-title>Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities</article-title>. <source/>Epilepsia. <year>2014</year>;<volume>55</volume>:<fpage>e25</fpage>–<lpage>29</lpage>. doi:<pub-id pub-id-type="doi">10.1111/epi.12554</pub-id>.<pub-id pub-id-type="pmid">24579881</pub-id></mixed-citation>
</ref>
<ref id="bibr13-1179573519849938">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Shirasaka</surname><given-names>Y</given-names></name><name><surname>Hirose</surname><given-names>S</given-names></name><name><surname>Sugawara</surname><given-names>T</given-names></name><name><surname>Yamakawa</surname><given-names>K.</given-names></name></person-group>
<article-title>Seizure phenotypes of a family with missense mutations in SCN2A</article-title>. <source/>Pediatr Neurol. <year>2004</year>;<volume>31</volume>:<fpage>150</fpage>–<lpage>152</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2004.02.013</pub-id>.<pub-id pub-id-type="pmid">15301839</pub-id></mixed-citation>
</ref>
<ref id="bibr14-1179573519849938">
<label>14</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Striano</surname><given-names>P</given-names></name><name><surname>Bordo</surname><given-names>L</given-names></name><name><surname>Lispi</surname><given-names>ML</given-names></name><etal>et al</etal></person-group>
<article-title>A novel SCN2A mutation in family with benign familial infantile seizures</article-title>. <source/>Epilepsia. <year>2006</year>;<volume>47</volume>:<fpage>218</fpage>–<lpage>220</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1167.2006.00392.x</pub-id>.<pub-id pub-id-type="pmid">16417554</pub-id></mixed-citation>
</ref>
<ref id="bibr15-1179573519849938">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>CP</given-names></name><name><surname>Lin</surname><given-names>SP</given-names></name><name><surname>Chern</surname><given-names>SR</given-names></name><etal>et al</etal></person-group>
<article-title>Array-CGH detection of a de novo 2.8 Mb deletion in 2q24.2—&gt;q24.3 in a girl with autistic features and developmental delay</article-title>. <source/>Eur J Med Genet. <year>2010</year>;<volume>53</volume>:<fpage>217</fpage>–<lpage>220</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ejmg.2010.03.006</pub-id>.<pub-id pub-id-type="pmid">20346423</pub-id></mixed-citation>
</ref>
<ref id="bibr16-1179573519849938">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Takatsuki</surname><given-names>S</given-names></name><name><surname>Nakamura</surname><given-names>R</given-names></name><name><surname>Haga</surname><given-names>Y</given-names></name><etal>et al</etal></person-group>
<article-title>Severe pulmonary emphysema in a girl with interstitial deletion of 2q24.2q24.3 including ITGB6</article-title>. <source/>Am J Med Genet A. <year>2010</year>;<volume>152A</volume>:<fpage>1020</fpage>–<lpage>1025</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ajmg.a.33362</pub-id>.<pub-id pub-id-type="pmid">20358620</pub-id></mixed-citation>
</ref>
<ref id="bibr17-1179573519849938">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Raymond</surname><given-names>G</given-names></name><name><surname>Wohler</surname><given-names>E</given-names></name><name><surname>Dinsmore</surname><given-names>C</given-names></name><etal>et al</etal></person-group>
<article-title>An interstitial duplication at 2q24.3 involving the SCN1A, SCN2A, SCN3A genes associated with infantile epilepsy</article-title>. <source/>Am J Med Genet A. <year>2011</year>;<volume>155A</volume>:<fpage>920</fpage>–<lpage>923</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ajmg.a.33929</pub-id>.<pub-id pub-id-type="pmid">21416599</pub-id></mixed-citation>
</ref>
<ref id="bibr18-1179573519849938">
<label>18</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Okumura</surname><given-names>A</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Shimojima</surname><given-names>K</given-names></name><etal>et al</etal></person-group>
<article-title>Refractory neonatal epilepsy with a de novo duplication of chromosome 2q24.2q24.3</article-title>. <source/>Epilepsia. <year>2011</year>;<volume>52</volume>:<fpage>e66</fpage>–<lpage>e69</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1167.2011.03139.x</pub-id>.<pub-id pub-id-type="pmid">21692795</pub-id></mixed-citation>
</ref>
<ref id="bibr19-1179573519849938">
<label>19</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vecchi</surname><given-names>M</given-names></name><name><surname>Cassina</surname><given-names>M</given-names></name><name><surname>Casarin</surname><given-names>A</given-names></name><etal>et al</etal></person-group>
<article-title>Infantile epilepsy associated with mosaic 2q24 duplication including SCN2A and SCN3A</article-title>. <source/>Seizure. <year>2011</year>;<volume>20</volume>:<fpage>813</fpage>–<lpage>816</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.seizure.2011.07.008.</pub-id><pub-id pub-id-type="pmid">21893419</pub-id></mixed-citation>
</ref>
<ref id="bibr20-1179573519849938">
<label>20</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sundaram</surname><given-names>SK</given-names></name><name><surname>Chugani</surname><given-names>HT</given-names></name><name><surname>Tiwari</surname><given-names>VN</given-names></name><name><surname>Huq</surname><given-names>AH.</given-names></name></person-group>
<article-title>SCN2A mutation is associated with infantile spasms and bitemporal glucose hypometabolism</article-title>. <source/>Pediatr Neurol. <year>2013</year>;<volume>49</volume>:<fpage>46</fpage>–<lpage>49</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2013.03.002</pub-id>.<pub-id pub-id-type="pmid">23827426</pub-id></mixed-citation>
</ref>
<ref id="bibr21-1179573519849938">
<label>21</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dhamija</surname><given-names>R</given-names></name><name><surname>Wirrell</surname><given-names>E</given-names></name><name><surname>Falcao</surname><given-names>G</given-names></name><name><surname>Kirmani</surname><given-names>S</given-names></name><name><surname>Wong-Kisiel</surname><given-names>LC.</given-names></name></person-group>
<article-title>Novel de novo SCN2A mutation in a child with migrating focal seizures of infancy</article-title>. <source/>Pediatr Neurol. <year>2013</year>;<volume>49</volume>:<fpage>486</fpage>–<lpage>488</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2013.07.004</pub-id>.<pub-id pub-id-type="pmid">23988467</pub-id></mixed-citation>
</ref>
<ref id="bibr22-1179573519849938">
<label>22</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tavassoli</surname><given-names>T</given-names></name><name><surname>Kolevzon</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>AT</given-names></name><etal>et al</etal></person-group>
<article-title>De novo SCN2A splice site mutation in a boy with Autism spectrum disorder</article-title>. <source/>BMC Med Genet. <year>2014</year>;<volume>15</volume>:<fpage>35</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1471-2350-15-35</pub-id>.<pub-id pub-id-type="pmid">24650168</pub-id></mixed-citation>
</ref>
<ref id="bibr23-1179573519849938">
<label>23</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Ohzono</surname><given-names>H</given-names></name><name><surname>Shinohara</surname><given-names>M</given-names></name><etal>et al</etal></person-group>
<article-title>Acute encephalopathy with a novel point mutation in the SCN2A gene</article-title>. <source/>Epilepsy Res. <year>2012</year>;<volume>102</volume>:<fpage>109</fpage>–<lpage>112</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.eplepsyres.2012.04.016</pub-id>.<pub-id pub-id-type="pmid">22591750</pub-id></mixed-citation>
</ref>
<ref id="bibr24-1179573519849938">
<label>24</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wong</surname><given-names>VC</given-names></name><name><surname>Fung</surname><given-names>CW</given-names></name><name><surname>Kwong</surname><given-names>AK.</given-names></name></person-group>
<article-title>SCN2A mutation in a Chinese boy with infantile spasm—response to modified Atkins diet</article-title>. <source/>Brain Dev. <year>2015</year>;<volume>37</volume>:<fpage>729</fpage>–<lpage>732</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.braindev.2014.10.008</pub-id>.<pub-id pub-id-type="pmid">25459969</pub-id></mixed-citation>
</ref>
<ref id="bibr25-1179573519849938">
<label>25</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Celle</surname><given-names>ME</given-names></name><name><surname>Cuoco</surname><given-names>C</given-names></name><name><surname>Porta</surname><given-names>S</given-names></name><name><surname>Gimelli</surname><given-names>G</given-names></name><name><surname>Tassano</surname><given-names>E.</given-names></name></person-group>
<article-title>Interstitial 2q24.3 deletion including SCN2A and SCN3A genes in a patient with autistic features, psychomotor delay, microcephaly and no history of seizures</article-title>. <source/>Gene. <year>2013</year>;<volume>532</volume>:<fpage>294</fpage>–<lpage>296</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.gene.2013.09.073</pub-id>.<pub-id pub-id-type="pmid">24080482</pub-id></mixed-citation>
</ref>
<ref id="bibr26-1179573519849938">
<label>26</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fukasawa</surname><given-names>T</given-names></name><name><surname>Kubota</surname><given-names>T</given-names></name><name><surname>Negoro</surname><given-names>T</given-names></name><etal>et al</etal></person-group>
<article-title>A case of recurrent encephalopathy with SCN2A missense mutation</article-title>. <source/>Brain Dev. <year>2015</year>;<volume>37</volume>:<fpage>631</fpage>–<lpage>634</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.braindev.2014.10.001</pub-id>.<pub-id pub-id-type="pmid">25457084</pub-id></mixed-citation>
</ref>
<ref id="bibr27-1179573519849938">
<label>27</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dimassi</surname><given-names>S</given-names></name><name><surname>Labalme</surname><given-names>A</given-names></name><name><surname>Ville</surname><given-names>D</given-names></name><etal>et al</etal></person-group>
<article-title>Whole-exome sequencing improves the diagnosis yield in sporadic infantile spasm syndrome</article-title>. <source/>Clin Genet. <year>2016</year>;<volume>89</volume>:<fpage>198</fpage>–<lpage>204</lpage>. doi:<pub-id pub-id-type="doi">10.1111/cge.12636</pub-id>.<pub-id pub-id-type="pmid">26138355</pub-id></mixed-citation>
</ref>
<ref id="bibr28-1179573519849938">
<label>28</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Horvath</surname><given-names>GA</given-names></name><name><surname>Demos</surname><given-names>M</given-names></name><name><surname>Shyr</surname><given-names>C</given-names></name><etal>et al</etal></person-group>
<article-title>Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channelopathies: a potential treatment target</article-title>. <source/>Mol Genet Metab. <year>2016</year>;<volume>117</volume>:<fpage>42</fpage>–<lpage>48</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ymgme.2015.11.008</pub-id>.<pub-id pub-id-type="pmid">26647175</pub-id></mixed-citation>
</ref>
<ref id="bibr29-1179573519849938">
<label>29</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gorman</surname><given-names>KM</given-names></name><name><surname>King</surname><given-names>MD.</given-names></name><name><surname>SCN2A</surname><given-names>p.</given-names></name></person-group>
<article-title>Ala263Val variant a phenotype of neonatal seizures followed by paroxysmal ataxia in toddlers</article-title>. <source/>Pediatr Neurol. <year>2017</year>;<volume>67</volume>:<fpage>111</fpage>–<lpage>112</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2016.11.008</pub-id>.<pub-id pub-id-type="pmid">28065826</pub-id></mixed-citation>
</ref>
<ref id="bibr30-1179573519849938">
<label>30</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saitoh</surname><given-names>M</given-names></name><name><surname>Ishii</surname><given-names>A</given-names></name><name><surname>Ihara</surname><given-names>Y</given-names></name><etal>et al</etal></person-group>
<article-title>Missense mutations in sodium channel SCN1A and SCN2A predispose children to encephalopathy with severe febrile seizures</article-title>. <source/>Epilepsy Res. <year>2015</year>;<volume>117</volume>:<fpage>1</fpage>–<lpage>6</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.eplepsyres.2015.08.001</pub-id>.<pub-id pub-id-type="pmid">26311622</pub-id></mixed-citation>
</ref>
<ref id="bibr31-1179573519849938">
<label>31</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zerem</surname><given-names>A</given-names></name><name><surname>Lev</surname><given-names>D</given-names></name><name><surname>Blumkin</surname><given-names>L</given-names></name><etal>et al</etal></person-group>
<article-title>Paternal germline mosaicism of a SCN2A mutation results in Ohtahara syndrome in half siblings</article-title>. <source/>Eur J Paediatr Neurol. <year>2014</year>;<volume>18</volume>:<fpage>567</fpage>–<lpage>571</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ejpn.2014.04.008</pub-id>.<pub-id pub-id-type="pmid">24814476</pub-id></mixed-citation>
</ref>
<ref id="bibr32-1179573519849938">
<label>32</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leach</surname><given-names>EL</given-names></name><name><surname>van Karnebeek</surname><given-names>CD</given-names></name><name><surname>Townsend</surname><given-names>KN</given-names></name><name><surname>Tarailo-Graovac</surname><given-names>M</given-names></name><name><surname>Hukin</surname><given-names>J</given-names></name><name><surname>Gibson</surname><given-names>WT.</given-names></name></person-group>
<article-title>Episodic ataxia associated with a de novo SCN2A mutation</article-title>. <source/>Eur J Paediatr Neurol. <year>2016</year>;<volume>20</volume>:<fpage>772</fpage>–<lpage>776</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ejpn.2016.05.020</pub-id>.<pub-id pub-id-type="pmid">27328862</pub-id></mixed-citation>
</ref>
<ref id="bibr33-1179573519849938">
<label>33</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dilena</surname><given-names>R</given-names></name><name><surname>Striano</surname><given-names>P</given-names></name><name><surname>Gennaro</surname><given-names>E</given-names></name><etal>et al</etal></person-group>
<article-title>Efficacy of sodium channel blockers in SCN2A early infantile epileptic encephalopathy</article-title>. <source/>Brain Dev. <year>2017</year>;<volume>39</volume>:<fpage>345</fpage>–<lpage>348</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.braindev.2016.10.015</pub-id>.<pub-id pub-id-type="pmid">27876397</pub-id></mixed-citation>
</ref>
<ref id="bibr34-1179573519849938">
<label>34</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>N</given-names></name><name><surname>Hahn</surname><given-names>A</given-names></name><name><surname>Bast</surname><given-names>T</given-names></name><etal>et al</etal></person-group>
<article-title>Mutations in the sodium channel gene SCN2A cause neonatal epilepsy with late-onset episodic ataxia</article-title>. <source/>J Neurol. <year>2016</year>;<volume>263</volume>:<fpage>334</fpage>–<lpage>343</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00415-015-7984-0</pub-id>.<pub-id pub-id-type="pmid">26645390</pub-id></mixed-citation>
</ref>
<ref id="bibr35-1179573519849938">
<label>35</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bernardo</surname><given-names>S</given-names></name><name><surname>Marchionni</surname><given-names>E</given-names></name><name><surname>Prudente</surname><given-names>S</given-names></name><etal>et al</etal></person-group>
<article-title>Unusual association of SCN2A epileptic encephalopathy with severe cortical dysplasia detected by prenatal MRI</article-title>. <source/>Eur J Paediatr Neurol. <year>2017</year>;<volume>21</volume>:<fpage>587</fpage>–<lpage>590</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ejpn.2017.01.014</pub-id>.<pub-id pub-id-type="pmid">28254201</pub-id></mixed-citation>
</ref>
<ref id="bibr36-1179573519849938">
<label>36</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lauxmann</surname><given-names>S</given-names></name><name><surname>Boutry-Kryza</surname><given-names>N</given-names></name><name><surname>Rivier</surname><given-names>C</given-names></name><etal>et al</etal></person-group>
<article-title>An SCN2A mutation in a family with infantile seizures from Madagascar reveals an increased subthreshold Na(+) current</article-title>. <source/>Epilepsia. <year>2013</year>;<volume>54</volume>:<fpage>e117</fpage>–121. doi:<pub-id pub-id-type="doi">10.1111/epi.12241</pub-id>.<pub-id pub-id-type="pmid">23758435</pub-id></mixed-citation>
</ref>
<ref id="bibr37-1179573519849938">
<label>37</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thuresson</surname><given-names>AC</given-names></name><name><surname>Van Buggenhout</surname><given-names>G</given-names></name><name><surname>Sheth</surname><given-names>F</given-names></name><etal>et al</etal></person-group>
<article-title>Whole gene duplication of SCN2A and SCN3A is associated with neonatal seizures and a normal intellectual development</article-title>. <source/>Clin Genet. <year>2017</year>;<volume>91</volume>:<fpage>106</fpage>–<lpage>110</lpage>. doi:<pub-id pub-id-type="doi">10.1111/cge.12797</pub-id>.<pub-id pub-id-type="pmid">27153334</pub-id></mixed-citation>
</ref>
<ref id="bibr38-1179573519849938">
<label>38</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grinton</surname><given-names>BE</given-names></name><name><surname>Heron</surname><given-names>SE</given-names></name><name><surname>Pelekanos</surname><given-names>JT</given-names></name><etal>et al</etal></person-group>
<article-title>Familial neonatal seizures in 36 families: Clinical and genetic features correlate with outcome</article-title>. <source/>Epilepsia. <year>2015</year>;<volume>56</volume>:<fpage>1071</fpage>–<lpage>1080</lpage>. doi:<pub-id pub-id-type="doi">10.1111/epi.13020</pub-id>.<pub-id pub-id-type="pmid">25982755</pub-id></mixed-citation>
</ref>
<ref id="bibr39-1179573519849938">
<label>39</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mantegazza</surname><given-names>M</given-names></name><name><surname>Gambardella</surname><given-names>A</given-names></name><name><surname>Rusconi</surname><given-names>R</given-names></name><etal>et al</etal></person-group>
<article-title>Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures</article-title>. <source/>Proc Natl Acad Sci U S A. <year>2005</year>;<volume>102</volume>:<fpage>18177</fpage>–<lpage>18182</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0506818102</pub-id>.<pub-id pub-id-type="pmid">16326807</pub-id></mixed-citation>
</ref>
<ref id="bibr40-1179573519849938">
<label>40</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moulard</surname><given-names>B</given-names></name><name><surname>Guipponi</surname><given-names>M</given-names></name><name><surname>Chaigne</surname><given-names>D</given-names></name><name><surname>Mouthon</surname><given-names>D</given-names></name><name><surname>Buresi</surname><given-names>C</given-names></name><name><surname>Malafosse</surname><given-names>A.</given-names></name></person-group>
<article-title>Identification of a new locus for generalized epilepsy with febrile seizures plus (GEFS+) on chromosome 2q24-q33</article-title>. <source/>Am J Hum Genet. <year>1999</year>;<volume>65</volume>:<fpage>1396</fpage>–<lpage>1400</lpage>. doi:<pub-id pub-id-type="doi">10.1086/302621</pub-id>.<pub-id pub-id-type="pmid">10521305</pub-id></mixed-citation>
</ref>
<ref id="bibr41-1179573519849938">
<label>41</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Singh</surname><given-names>NA</given-names></name><name><surname>Pappas</surname><given-names>C</given-names></name><name><surname>Dahle</surname><given-names>EJ</given-names></name><etal>et al</etal></person-group>
<article-title>A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome</article-title>. <source/>PLoS Genet. <year>2009</year>;<volume>5</volume>:<fpage>e1000649</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pgen.1000649</pub-id>.<pub-id pub-id-type="pmid">19763161</pub-id></mixed-citation>
</ref>
<ref id="bibr42-1179573519849938">
<label>42</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Depienne</surname><given-names>C</given-names></name><name><surname>Trouillard</surname><given-names>O</given-names></name><name><surname>Gourfinkel-An</surname><given-names>I</given-names></name><etal>et al</etal></person-group>
<article-title>Mechanisms for variable expressivity of inherited SCN1A mutations causing Dravet syndrome</article-title>. <source/>J Med Genet. <year>2010</year>;<volume>47</volume>:<fpage>404</fpage>–<lpage>410</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jmg.2009.074328</pub-id>.<pub-id pub-id-type="pmid">20522430</pub-id></mixed-citation>
</ref>
<ref id="bibr43-1179573519849938">
<label>43</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Depienne</surname><given-names>C</given-names></name><name><surname>Trouillard</surname><given-names>O</given-names></name><name><surname>Saint-Martin</surname><given-names>C</given-names></name><etal>et al</etal></person-group>
<article-title>Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients</article-title>. <source/>J Med Genet. <year>2009</year>;<volume>46</volume>:<fpage>183</fpage>–<lpage>191</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jmg.2008.062323</pub-id>.<pub-id pub-id-type="pmid">18930999</pub-id></mixed-citation>
</ref>
<ref id="bibr44-1179573519849938">
<label>44</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Riva</surname><given-names>D</given-names></name><name><surname>Vago</surname><given-names>C</given-names></name><name><surname>Pantaleoni</surname><given-names>C</given-names></name><name><surname>Bulgheroni</surname><given-names>S</given-names></name><name><surname>Mantegazza</surname><given-names>M</given-names></name><name><surname>Franceschetti</surname><given-names>S.</given-names></name></person-group>
<article-title>Progressive neurocognitive decline in two children with Dravet syndrome, de novo SCN1A truncations and different epileptic phenotypes</article-title>. <source/>Am J Med Genet A. <year>2009</year>;<volume>149A</volume>:<fpage>2339</fpage>–<lpage>2345</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ajmg.a.33029</pub-id>.<pub-id pub-id-type="pmid">19764027</pub-id></mixed-citation>
</ref>
<ref id="bibr45-1179573519849938">
<label>45</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heron</surname><given-names>SE</given-names></name><name><surname>Scheffer</surname><given-names>IE</given-names></name><name><surname>Iona</surname><given-names>X</given-names></name><etal>et al</etal></person-group>
<article-title>De novo SCN1A mutations in Dravet syndrome and related epileptic encephalopathies are largely of paternal origin</article-title>. <source/>J Med Genet. <year>2010</year>;<volume>47</volume>:<fpage>137</fpage>–<lpage>141</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jmg.2008.065912</pub-id>.<pub-id pub-id-type="pmid">19589774</pub-id></mixed-citation>
</ref>
<ref id="bibr46-1179573519849938">
<label>46</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>de Kovel</surname><given-names>CG</given-names></name><name><surname>Meisler</surname><given-names>MH</given-names></name><name><surname>Brilstra</surname><given-names>EH</given-names></name><etal>et al</etal></person-group>
<article-title>Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathy</article-title>. <source/>Epilepsy Res. <year>2014</year>;<volume>108</volume>:<fpage>1511</fpage>–<lpage>1518</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.eplepsyres.2014.08.020</pub-id>.<pub-id pub-id-type="pmid">25239001</pub-id></mixed-citation>
</ref>
<ref id="bibr47-1179573519849938">
<label>47</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Veeramah</surname><given-names>KR</given-names></name><name><surname>O‘Brien</surname><given-names>JE</given-names></name><name><surname>Meisler</surname><given-names>MH</given-names></name><etal>et al</etal></person-group>
<article-title>De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP</article-title>. <source/>Am J Hum Genet. <year>2012</year>;<volume>90</volume>:<fpage>502</fpage>–<lpage>510</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ajhg.2012.01.006</pub-id>.<pub-id pub-id-type="pmid">22365152</pub-id></mixed-citation>
</ref>
<ref id="bibr48-1179573519849938">
<label>48</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wallace</surname><given-names>RH</given-names></name><name><surname>Wang</surname><given-names>DW</given-names></name><name><surname>Singh</surname><given-names>R</given-names></name><etal>et al</etal></person-group>
<article-title>Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B</article-title>. <source/>Nat Genet. <year>1998</year>;<volume>19</volume>:<fpage>366</fpage>–<lpage>370</lpage>. doi:<pub-id pub-id-type="doi">10.1038/1252</pub-id>.<pub-id pub-id-type="pmid">9697698</pub-id></mixed-citation>
</ref>
<ref id="bibr49-1179573519849938">
<label>49</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ogiwara</surname><given-names>I</given-names></name><name><surname>Nakayama</surname><given-names>T</given-names></name><name><surname>Yamagata</surname><given-names>T</given-names></name><etal>et al</etal></person-group>
<article-title>A homozygous mutation of voltage-gated sodium channel beta(I) gene SCN1B in a patient with Dravet syndrome</article-title>. <source/>Epilepsia. <year>2012</year>;<volume>53</volume>:<fpage>e200</fpage>–<lpage>e203</lpage>. doi:<pub-id pub-id-type="doi">10.1111/epi.12040</pub-id>.<pub-id pub-id-type="pmid">23148524</pub-id></mixed-citation>
</ref>
<ref id="bibr50-1179573519849938">
<label>50</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jiang</surname><given-names>YH</given-names></name><name><surname>Yuen</surname><given-names>RK</given-names></name><name><surname>Jin</surname><given-names>X</given-names></name><etal>et al</etal></person-group>
<article-title>Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing</article-title>. <source/>Am J Hum Genet. <year>2013</year>;<volume>93</volume>:<fpage>249</fpage>–<lpage>263</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ajhg.2013.06.012</pub-id>.<pub-id pub-id-type="pmid">23849776</pub-id></mixed-citation>
</ref>
<ref id="bibr51-1179573519849938">
<label>51</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carroll</surname><given-names>LS</given-names></name><name><surname>Woolf</surname><given-names>R</given-names></name><name><surname>Ibrahim</surname><given-names>Y</given-names></name><etal>et al</etal></person-group>
<article-title>Mutation screening of SCN2A in schizophrenia and identification of a novel loss-of-function mutation</article-title>. <source/>Psychiatr Genet. <year>2016</year>;<volume>26</volume>:<fpage>60</fpage>–<lpage>65</lpage>. doi:<pub-id pub-id-type="doi">10.1097/YPG.0000000000000110</pub-id>.<pub-id pub-id-type="pmid">26555645</pub-id></mixed-citation>
</ref>
<ref id="bibr52-1179573519849938">
<label>52</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lemke</surname><given-names>JR</given-names></name><name><surname>Riesch</surname><given-names>E</given-names></name><name><surname>Scheurenbrand</surname><given-names>T</given-names></name><etal>et al</etal></person-group>
<article-title>Targeted next generation sequencing as a diagnostic tool in epileptic disorders</article-title>. <source/>Epilepsia. <year>2012</year>;<volume>53</volume>:<fpage>1387</fpage>–<lpage>1398</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1528-1167.2012.03516.x</pub-id>.<pub-id pub-id-type="pmid">22612257</pub-id></mixed-citation>
</ref>
<ref id="bibr53-1179573519849938">
<label>53</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Su</surname><given-names>DJ</given-names></name><name><surname>Lu</surname><given-names>JF</given-names></name><name><surname>Lin</surname><given-names>LJ</given-names></name><name><surname>Liang</surname><given-names>JS</given-names></name><name><surname>Hung</surname><given-names>KL.</given-names></name></person-group>
<article-title>SCN2A mutation in an infant presenting with migrating focal seizures and infantile spasm responsive to a ketogenic diet</article-title>. <source/>Brain Dev. <year>2018</year>;<volume>40</volume>:<fpage>724</fpage>–<lpage>727</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.braindev.2018.03.005</pub-id>.<pub-id pub-id-type="pmid">29625812</pub-id></mixed-citation>
</ref>
<ref id="bibr54-1179573519849938">
<label>54</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Yasumoto</surname><given-names>S</given-names></name><name><surname>Nakagawa</surname><given-names>E</given-names></name><name><surname>Fukasawa</surname><given-names>T</given-names></name><name><surname>Uchiya</surname><given-names>S</given-names></name><name><surname>Hirose</surname><given-names>S.</given-names></name></person-group>
<article-title>Missense mutation of the sodium channel gene SCN2A causes Dravet syndrome</article-title>. <source/>Brain Dev. <year>2009</year>;<volume>31</volume>:<fpage>758</fpage>–<lpage>762</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.braindev.2009.08.009</pub-id>.<pub-id pub-id-type="pmid">19783390</pub-id></mixed-citation>
</ref>
<ref id="bibr55-1179573519849938">
<label>55</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Herlenius</surname><given-names>E</given-names></name><name><surname>Heron</surname><given-names>SE</given-names></name><name><surname>Grinton</surname><given-names>BE</given-names></name><etal>et al</etal></person-group>
<article-title>SCN2A mutations and benign familial neonatal-infantile seizures: the phenotypic spectrum</article-title>. <source/>Epilepsia. <year>2007</year>;<volume>48</volume>:<fpage>1138</fpage>–<lpage>1142</lpage>.<pub-id pub-id-type="pmid">17386050</pub-id></mixed-citation>
</ref>
<ref id="bibr56-1179573519849938">
<label>56</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moller</surname><given-names>RS</given-names></name><name><surname>Larsen</surname><given-names>LH</given-names></name><name><surname>Johannesen</surname><given-names>KM</given-names></name><etal>et al</etal></person-group>
<article-title>Gene panel testing in epileptic encephalopathies and familial epilepsies</article-title>. <source/>Mol Syndromol. <year>2016</year>;<volume>7</volume>:<fpage>210</fpage>–<lpage>219</lpage>.<pub-id pub-id-type="pmid">27781031</pub-id></mixed-citation>
</ref>
<ref id="bibr57-1179573519849938">
<label>57</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Della Mina</surname><given-names>E</given-names></name><name><surname>Ciccone</surname><given-names>R</given-names></name><name><surname>Brustia</surname><given-names>F</given-names></name><etal>et al</etal></person-group>
<article-title>Improving molecular diagnosis in epilepsy by a dedicated high-throughput sequencing platform</article-title>. <source/>Eur J Hum Genet. <year>2015</year>;<volume>23</volume>:<fpage>354</fpage>–<lpage>362</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ejhg.2014.92</pub-id>.<pub-id pub-id-type="pmid">24848745</pub-id></mixed-citation>
</ref>
<ref id="bibr58-1179573519849938">
<label>58</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grozeva</surname><given-names>D</given-names></name><name><surname>Carss</surname><given-names>K</given-names></name><name><surname>Spasic-Boskovic</surname><given-names>O</given-names></name><etal>et al</etal></person-group>
<article-title>Targeted Next-Generation Sequencing Analysis of 1,000 Individuals with Intellectual Disability</article-title>. <source/>Hum Mutat. <year>2015</year>;<volume>36</volume>:<fpage>1197</fpage>–<lpage>1204</lpage>. doi:<pub-id pub-id-type="doi">10.1002/humu.22901</pub-id>.<pub-id pub-id-type="pmid">26350204</pub-id></mixed-citation>
</ref>
<ref id="bibr59-1179573519849938">
<label>59</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Willig</surname><given-names>LK</given-names></name><name><surname>Petrikin</surname><given-names>JE</given-names></name><name><surname>Smith</surname><given-names>LD</given-names></name><etal>et al</etal></person-group>
<article-title>Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings</article-title>. <source/>Lancet Respir Med. <year>2015</year>;<volume>3</volume>:<fpage>377</fpage>–<lpage>387</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S2213-2600(15)00139-3</pub-id>.<pub-id pub-id-type="pmid">25937001</pub-id></mixed-citation>
</ref>
<ref id="bibr60-1179573519849938">
<label>60</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zara</surname><given-names>F</given-names></name><name><surname>Specchio</surname><given-names>N</given-names></name><name><surname>Striano</surname><given-names>P</given-names></name><etal>et al</etal></person-group>
<article-title>Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance</article-title>. <source/>Epilepsia. <year>2013</year>;<volume>54</volume>:<fpage>425</fpage>–<lpage>436</lpage>. doi:<pub-id pub-id-type="doi">10.1111/epi.12089</pub-id>.<pub-id pub-id-type="pmid">23360469</pub-id></mixed-citation>
</ref>
<ref id="bibr61-1179573519849938">
<label>61</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Takezawa</surname><given-names>Y</given-names></name><name><surname>Kikuchi</surname><given-names>A</given-names></name><name><surname>Haginoya</surname><given-names>K</given-names></name><etal>et al</etal></person-group>
<article-title>Genomic analysis identifies masqueraders of full-term cerebral palsy</article-title>. <source/>Ann Clin Transl Neurol. <year>2018</year>;<volume>5</volume>:<fpage>538</fpage>–<lpage>551</lpage>. doi:<pub-id pub-id-type="doi">10.1002/acn3.551</pub-id>.<pub-id pub-id-type="pmid">29761117</pub-id></mixed-citation>
</ref>
<ref id="bibr62-1179573519849938">
<label>62</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Martin</surname><given-names>HC</given-names></name><name><surname>Kim</surname><given-names>GE</given-names></name><name><surname>Pagnamenta</surname><given-names>AT</given-names></name><etal>et al</etal></person-group>
<article-title>Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis</article-title>. <source/>Hum Mol Genet. <year>2014</year>;<volume>23</volume>:<fpage>3200</fpage>–<lpage>3211</lpage>. doi:<pub-id pub-id-type="doi">10.1093/hmg/ddu030</pub-id>.<pub-id pub-id-type="pmid">24463883</pub-id></mixed-citation>
</ref>
<ref id="bibr63-1179573519849938">
<label>63</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cherot</surname><given-names>E</given-names></name><name><surname>Keren</surname><given-names>B</given-names></name><name><surname>Dubourg</surname><given-names>C</given-names></name><etal>et al</etal></person-group>
<article-title>Using medical exome sequencing to identify the causes of neurodevelopmental disorders: experience of 2 clinical units and 216 patients</article-title>. <source/>Clin Genet. <year>2018</year>;<volume>93</volume>:<fpage>567</fpage>–<lpage>576</lpage>. doi:<pub-id pub-id-type="doi">10.1111/cge.13102</pub-id>.<pub-id pub-id-type="pmid">28708303</pub-id></mixed-citation>
</ref>
<ref id="bibr64-1179573519849938">
<label>64</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>C Yuen</surname><given-names>RK</given-names></name><name><surname>Merico</surname><given-names>D</given-names></name><name><surname>Bookman</surname><given-names>M</given-names></name><etal>et al</etal></person-group>
<article-title>Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder</article-title>. <source/>Nat Neurosci. <year>2017</year>;<volume>20</volume>:<fpage>602</fpage>–<lpage>611</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nn.4524</pub-id>.<pub-id pub-id-type="pmid">28263302</pub-id></mixed-citation>
</ref>
<ref id="bibr65-1179573519849938">
<label>65</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rauch</surname><given-names>A</given-names></name><name><surname>Wieczorek</surname><given-names>D</given-names></name><name><surname>Graf</surname><given-names>E</given-names></name><etal>et al</etal></person-group>
<article-title>Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study</article-title>. <source/>Lancet. <year>2012</year>;<volume>380</volume>:<fpage>1674</fpage>–<lpage>1682</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(12)61480-9</pub-id>.<pub-id pub-id-type="pmid">23020937</pub-id></mixed-citation>
</ref>
<ref id="bibr66-1179573519849938">
<label>66</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kosmicki</surname><given-names>JA</given-names></name><name><surname>Samocha</surname><given-names>KE</given-names></name><name><surname>Howrigan</surname><given-names>DP</given-names></name><etal>et al</etal></person-group>
<article-title>Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples</article-title>. <source/>Nat Genet. <year>2017</year>;<volume>49</volume>:<fpage>504</fpage>–<lpage>510</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng.3789.</pub-id><pub-id pub-id-type="pmid">28191890</pub-id></mixed-citation>
</ref>
<ref id="bibr67-1179573519849938">
<label>67</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bruun</surname><given-names>TUJ</given-names></name><name><surname>DesRoches</surname><given-names>CL</given-names></name><name><surname>Wilson</surname><given-names>D</given-names></name><etal>et al</etal></person-group>
<article-title>Prospective cohort study for identification of underlying genetic causes in neonatal encephalopathy using whole-exome sequencing</article-title>. <source/>Genet Med. <year>2018</year>;<volume>20</volume>:<fpage>486</fpage>–<lpage>494</lpage>. doi:<pub-id pub-id-type="doi">10.1038/gim.2017.129</pub-id>.<pub-id pub-id-type="pmid">28817111</pub-id></mixed-citation>
</ref>
<ref id="bibr68-1179573519849938">
<label>68</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Butler</surname><given-names>KM</given-names></name><name><surname>da Silva</surname><given-names>C</given-names></name><name><surname>Alexander</surname><given-names>JJ</given-names></name><name><surname>Hegde</surname><given-names>M</given-names></name><name><surname>Escayg</surname><given-names>A.</given-names></name></person-group>
<article-title>Diagnostic yield from 339 epilepsy patients screened on a clinical gene panel</article-title>. <source/>Pediatr Neurol. <year>2017</year>;<volume>77</volume>:<fpage>61</fpage>–<lpage>66</lpage> doi:<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2017.09.003</pub-id>.<pub-id pub-id-type="pmid">29056246</pub-id></mixed-citation>
</ref>
<ref id="bibr69-1179573519849938">
<label>69</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carvill</surname><given-names>GL</given-names></name><name><surname>Heavin</surname><given-names>SB</given-names></name><name><surname>Yendle</surname><given-names>SC</given-names></name><etal>et al</etal></person-group>
<article-title>Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1</article-title>. <source/>Nat Genet. <year>2013</year>;<volume>45</volume>:<fpage>825</fpage>–<lpage>830</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng.2646</pub-id>.<pub-id pub-id-type="pmid">23708187</pub-id></mixed-citation>
</ref>
<ref id="bibr70-1179573519849938">
<label>70</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chong</surname><given-names>PF</given-names></name><name><surname>Saitsu</surname><given-names>H</given-names></name><name><surname>Sakai</surname><given-names>Y</given-names></name><etal>et al</etal></person-group>
<article-title>Deletions of SCN2A and SCN3A genes in a patient with West syndrome and autistic spectrum disorder</article-title>. <source/>Seizure. <year>2018</year>;<volume>60</volume>:<fpage>91</fpage>–<lpage>93</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.seizure.2018.06.012</pub-id>.<pub-id pub-id-type="pmid">29929112</pub-id></mixed-citation>
</ref>
<ref id="bibr71-1179573519849938">
<label>71</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fokstuen</surname><given-names>S</given-names></name><name><surname>Makrythanasis</surname><given-names>P</given-names></name><name><surname>Hammar</surname><given-names>E</given-names></name><etal>et al</etal></person-group>
<article-title>Experience of a multidisciplinary task force with exome sequencing for Mendelian disorders</article-title>. <source/>Hum Genomics. <year>2016</year>;<volume>10</volume>:<fpage>24</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s40246-016-0080-4</pub-id>.<pub-id pub-id-type="pmid">27353043</pub-id></mixed-citation>
</ref>
<ref id="bibr72-1179573519849938">
<label>72</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gokben</surname><given-names>S</given-names></name><name><surname>Onay</surname><given-names>H</given-names></name><name><surname>Yilmaz</surname><given-names>S</given-names></name><etal>et al</etal></person-group>
<article-title>Targeted next generation sequencing: the diagnostic value in early-onset epileptic encephalopathy</article-title>. <source/>Acta Neurol Belg. <year>2017</year>;<volume>117</volume>:<fpage>131</fpage>–<lpage>138</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s13760-016-0709-z</pub-id>.<pub-id pub-id-type="pmid">27734276</pub-id></mixed-citation>
</ref>
<ref id="bibr73-1179573519849938">
<label>73</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Helbig</surname><given-names>KL</given-names></name><name><surname>Farwell Hagman</surname><given-names>KD</given-names></name><name><surname>Shinde</surname><given-names>DN</given-names></name><etal>et al</etal></person-group>
<article-title>Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy</article-title>. <source/>Genet Med. <year>2016</year>;<volume>18</volume>:<fpage>898</fpage>–<lpage>905</lpage>. doi:<pub-id pub-id-type="doi">10.1038/gim.2015.186</pub-id>.<pub-id pub-id-type="pmid">26795593</pub-id></mixed-citation>
</ref>
<ref id="bibr74-1179573519849938">
<label>74</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kothur</surname><given-names>K</given-names></name><name><surname>Holman</surname><given-names>K</given-names></name><name><surname>Farnsworth</surname><given-names>E</given-names></name><etal>et al</etal></person-group>
<article-title>Diagnostic yield of targeted massively parallel sequencing in children with epileptic encephalopathy</article-title>. <source/>Seizure. <year>2018</year>;<volume>59</volume>:<fpage>132</fpage>–<lpage>140</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.seizure.2018.05.005</pub-id>.<pub-id pub-id-type="pmid">29852413</pub-id></mixed-citation>
</ref>
<ref id="bibr75-1179573519849938">
<label>75</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liang</surname><given-names>JS</given-names></name><name><surname>Lin</surname><given-names>LJ</given-names></name><name><surname>Yang</surname><given-names>MT</given-names></name><name><surname>Wang</surname><given-names>JS</given-names></name><name><surname>Lu</surname><given-names>JF.</given-names></name></person-group>
<article-title>The therapeutic implication of a novel SCN2A mutation associated early-onset epileptic encephalopathy with Rett-like features</article-title>. <source/>Brain Dev. <year>2017</year>;<volume>39</volume>:<fpage>877</fpage>–<lpage>881</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.braindev.2017.06.003</pub-id>.<pub-id pub-id-type="pmid">28709814</pub-id></mixed-citation>
</ref>
<ref id="bibr76-1179573519849938">
<label>76</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mercimek-Mahmutoglu Patel</surname><given-names>J</given-names></name><name><surname>Cordeiro</surname><given-names>D</given-names></name><name><surname>Hewson</surname><given-names>S</given-names></name><etal>et al</etal></person-group>
<article-title>Diagnostic yield of genetic testing in epileptic encephalopathy in childhood</article-title>. <source/>Epilepsia. <year>2015</year>;<volume>56</volume>:<fpage>707</fpage>–<lpage>716</lpage>. doi:<pub-id pub-id-type="doi">10.1111/epi.12954</pub-id>.<pub-id pub-id-type="pmid">25818041</pub-id></mixed-citation>
</ref>
<ref id="bibr77-1179573519849938">
<label>77</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Olson</surname><given-names>HE</given-names></name><name><surname>Kelly</surname><given-names>M</given-names></name><name><surname>LaCoursiere</surname><given-names>CM</given-names></name><etal>et al</etal></person-group>
<article-title>Genetics and genotype-phenotype correlations in early onset epileptic encephalopathy with burst suppression</article-title>. <source/>Ann Neurol. <year>2017</year>;<volume>81</volume>:<fpage>419</fpage>–<lpage>429</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ana.24883</pub-id>.<pub-id pub-id-type="pmid">28133863</pub-id></mixed-citation>
</ref>
<ref id="bibr78-1179573519849938">
<label>78</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ostrander</surname><given-names>BEP</given-names></name><name><surname>Butterfield</surname><given-names>RJ</given-names></name><name><surname>Pedersen</surname><given-names>BS</given-names></name><etal>et al</etal></person-group>
<article-title>Whole-genome analysis for effective clinical diagnosis and gene discovery in early infantile epileptic encephalopathy</article-title>. <source/>NPJ Genom Med. <year>2018</year>;<volume>3</volume>:<fpage>22</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41525-018-0061-8</pub-id>.<pub-id pub-id-type="pmid">30109124</pub-id></mixed-citation>
</ref>
<ref id="bibr79-1179573519849938">
<label>79</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Palmer</surname><given-names>EE</given-names></name><name><surname>Schofield</surname><given-names>D</given-names></name><name><surname>Shrestha</surname><given-names>R</given-names></name><etal>et al</etal></person-group>
<article-title>Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: Evidence of clinical utility and cost effectiveness</article-title>. <source/>Mol Genet Genomic Med. <year>2018</year>;<volume>6</volume>:<fpage>186</fpage>–<lpage>199</lpage>. doi:<pub-id pub-id-type="doi">10.1002/mgg3.355</pub-id>.<pub-id pub-id-type="pmid">29314763</pub-id></mixed-citation>
</ref>
<ref id="bibr80-1179573519849938">
<label>80</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Parrini</surname><given-names>E</given-names></name><name><surname>Marini</surname><given-names>C</given-names></name><name><surname>Mei</surname><given-names>D</given-names></name><etal>et al</etal></person-group>
<article-title>Diagnostic targeted resequencing in 349 patients with drug-resistant pediatric epilepsies identifies causative mutations in 30 different genes</article-title>. <source/>Hum Mutat. <year>2017</year>;<volume>38</volume>:<fpage>216</fpage>–<lpage>225</lpage>. doi:<pub-id pub-id-type="doi">10.1002/humu.23149</pub-id>.<pub-id pub-id-type="pmid">27864847</pub-id></mixed-citation>
</ref>
<ref id="bibr81-1179573519849938">
<label>81</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matalon</surname><given-names>D</given-names></name><name><surname>Goldberg</surname><given-names>E</given-names></name><name><surname>Medne</surname><given-names>L</given-names></name><name><surname>Marsh</surname><given-names>ED</given-names></name></person-group> . <article-title>Confirming an expanded spectrum of SCN2A mutations: a case series</article-title>. <source/>Epileptic Disord. <year>2014</year>;<volume>16</volume>:<fpage>13</fpage>–<lpage>18</lpage>. doi:<pub-id pub-id-type="doi">10.1684/epd.2014.0641</pub-id>.<pub-id pub-id-type="pmid">24659627</pub-id></mixed-citation>
</ref>
<ref id="bibr82-1179573519849938">
<label>82</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Soden</surname><given-names>SE</given-names></name><name><surname>Saunders</surname><given-names>CJ</given-names></name><name><surname>Willig</surname><given-names>LK</given-names></name><etal>et al</etal></person-group>
<article-title>Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders</article-title>. <source/>Sci Transl Med. <year>2014</year>;<volume>6</volume>:<fpage>265ra168</fpage>. doi:<pub-id pub-id-type="doi">10.1126/scitranslmed.3010076</pub-id>.</mixed-citation>
</ref>
<ref id="bibr83-1179573519849938">
<label>83</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>S</given-names></name><name><surname>Cohen</surname><given-names>JS</given-names></name><name><surname>Vernon</surname><given-names>H</given-names></name><etal>et al</etal></person-group>
<article-title>Clinical whole exome sequencing in child neurology practice</article-title>. <source/>Ann Neurol. <year>2014</year>;<volume>76</volume>:<fpage>473</fpage>–<lpage>483</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ana.24251</pub-id>.<pub-id pub-id-type="pmid">25131622</pub-id></mixed-citation>
</ref>
<ref id="bibr84-1179573519849938">
<label>84</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stanek</surname><given-names>D</given-names></name><name><surname>Lassuthova</surname><given-names>P</given-names></name><name><surname>Sterbova</surname><given-names>K</given-names></name><etal>et al</etal></person-group>
<article-title>Detection rate of causal variants in severe childhood epilepsy is highest in patients with seizure onset within the first four weeks of life</article-title>. <source/>Orphanet J Rare Dis. <year>2018</year>;<volume>13</volume>:<fpage>71</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13023-018-0812-8</pub-id>.<pub-id pub-id-type="pmid">29720203</pub-id></mixed-citation>
</ref>
<ref id="bibr85-1179573519849938">
<label>85</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Trujillano</surname><given-names>D</given-names></name><name><surname>Bertoli-Avella</surname><given-names>AM</given-names></name><name><surname>Kumar Kandaswamy</surname><given-names>K</given-names></name><etal>et al</etal></person-group>
<article-title>Clinical exome sequencing: results from 2819 samples reflecting 1000 families</article-title>. <source/>Eur J Hum Genet. <year>2017</year>;<volume>25</volume>:<fpage>176</fpage>–<lpage>182</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ejhg.2016.146</pub-id>.<pub-id pub-id-type="pmid">27848944</pub-id></mixed-citation>
</ref>
<ref id="bibr86-1179573519849938">
<label>86</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Trump</surname><given-names>N</given-names></name><name><surname>McTague</surname><given-names>A</given-names></name><name><surname>Brittain</surname><given-names>H</given-names></name><etal>et al</etal></person-group>
<article-title>Improving diagnosis and broadening the phenotypes in early-onset seizure and severe developmental delay disorders through gene panel analysis</article-title>. <source/>J Med Genet. <year>2016</year>;<volume>53</volume>:<fpage>310</fpage>–<lpage>317</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jmedgenet-2015-103263</pub-id>.<pub-id pub-id-type="pmid">26993267</pub-id></mixed-citation>
</ref>
<ref id="bibr87-1179573519849938">
<label>87</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Xiong</surname><given-names>B</given-names></name><etal>et al</etal></person-group>
<article-title>De novo genic mutations among a Chinese autism spectrum disorder cohort</article-title>. <source/>Nat Commun. <year>2016</year>;<volume>7</volume>:<fpage>13316</fpage>. doi:<pub-id pub-id-type="doi">10.1038/ncomms13316</pub-id>.<pub-id pub-id-type="pmid">27824329</pub-id></mixed-citation>
</ref>
<ref id="bibr88-1179573519849938">
<label>88</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zeng</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><etal>et al</etal></person-group>
<article-title>Genetic analysis of benign familial epilepsies in the first year of life in a Chinese cohort</article-title>. <source/>J Hum Genet. <year>2018</year>;<volume>63</volume>:<fpage>9</fpage>–<lpage>18</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s10038-017-0359-x</pub-id>.<pub-id pub-id-type="pmid">29215089</pub-id></mixed-citation>
</ref>
<ref id="bibr89-1179573519849938">
<label>89</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Bao</surname><given-names>X</given-names></name><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name></person-group>
<article-title>Gene mutation analysis of 175 Chinese patients with early-onset epileptic encephalopathy</article-title>. <source/>Clin Genet. <year>2017</year>;<volume>91</volume>:<fpage>717</fpage>–<lpage>724</lpage>. doi:<pub-id pub-id-type="doi">10.1111/cge.12901</pub-id>.<pub-id pub-id-type="pmid">27779742</pub-id></mixed-citation>
</ref>
<ref id="bibr90-1179573519849938">
<label>90</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Padmanabhan</surname><given-names>R</given-names></name><name><surname>Copeland</surname><given-names>B</given-names></name><etal>et al</etal></person-group>
<article-title>A case-control collapsing analysis identifies epilepsy genes implicated in trio sequencing studies focused on de novo mutations</article-title>. <source/>PLoS Genet. <year>2017</year>;<volume>13</volume>:e1007104. doi:<pub-id pub-id-type="doi">10.1371/journal.pgen.1007104</pub-id>.</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>